Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555)

Maurizio Battaglia Parodi; Pierluigi Iacono

doi:10.1016/j.ophtha.2018.11.004

Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555)

Maurizio Battaglia Parodi, Pierluigi Iacono

Fondazione G.B. Bietti

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e29-e30
Journal	Ophthalmology
Volume	126
Issue number	4
DOIs	https://doi.org/10.1016/j.ophtha.2018.11.004
Publication status	Published - Apr 2019

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/j.ophtha.2018.11.004

Cite this

Re : van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555). / Battaglia Parodi, Maurizio; Iacono, Pierluigi.

In: Ophthalmology, Vol. 126, No. 4, 04.2019, p. e29-e30.

Research output: Contribution to journal › Letter › peer-review

@article{bc7a82467e0a4997a3c09d54fc74e55d,

title = "Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555)",

author = "{Battaglia Parodi}, Maurizio and Pierluigi Iacono",

year = "2019",

month = apr,

doi = "10.1016/j.ophtha.2018.11.004",

language = "English",

volume = "126",

pages = "e29--e30",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Re

T2 - van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555)

AU - Battaglia Parodi, Maurizio

AU - Iacono, Pierluigi

PY - 2019/4

Y1 - 2019/4

UR - http://www.scopus.com/inward/record.url?scp=85062710477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062710477&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2018.11.004

DO - 10.1016/j.ophtha.2018.11.004

M3 - Letter

C2 - 30910047

AN - SCOPUS:85062710477

VL - 126

SP - e29-e30

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 4

ER -